TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 1 | 1 | -4 | -10 | 24 | 15 | -27 | -0 |
S | %wins | 0 | 100 | 100 | 0 | 0 | 100 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/2/22 16:47 | 5/31/22 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dugan Richard W | PA | D | S.d | -64 | 9.85 | 0 | -7 | -9 | 68 | D | |||||||||||||||
2/18/21 20:43 | 2/16/21 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dugan Richard W | PA | D | S.d | -107 | 18.54 | 0 | -6 | -9 | 55 | D | |||||||||||||||
5/29/20 16:10 | 5/28/20 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dugan Richard W | PA | D | S.d | -112 | 11.04 | 0 | -10 | -20 | 41 | D | |||||||||||||||
8/28/19 16:30 | 8/26/19 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dugan Richard W | PA | D | S.d | -223 | 14.85 | 0 | -15 | -30 | 36 | D | |||||||||||||||
3/10/15 16:32 | 3/9/15 | VNDA | Vanda Pharmaceuticals Inc. | DE | Health | Drug | Pharmaceutical Preparations | Dugan Richard W | PA | D | S.d | -51 | 10.69 | 10 | -5 | -45 | 6 | D | 184 | -30 | -16 | -13 | -13 | -19 | -4 | -4 | 1 | -4 | -10 | 24 | 15 | -27 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |